Improved GI Tolerance, Quality of Life, and Weight Gain in an Adult Ulcerative Colitis, Renal Transplant Patient using a Plant-based Diabetes Specific Enteral Formula1
Authors: Kalee Eichelberger, RD, LDN, CNSC2; Melissa Bailey, MS, RD, CNSC, LDN3
Abstract presented at The American Society for Parenteral and Enteral Nutrition (ASPEN) 2023 Nutrition Science & Practice Conference and published in the supplement of the Journal of Parenteral and Enteral Nutrition (JPEN).
Summary: This case study assessed tolerance, weight gain, and quality of life (QoL) in an adult Ulcerative Colitis (UC) patient status post renal transplant consuming a plant-based, fiber-containing diabetes specific enteral formula (PBDF) orally at a single adult gastroenterology center.
Key Takeaways:
Use of a PBDF (Kate Farms Glucose Support 1.2) in this patient with Ulcerative Colitis and diabetes, status-post renal transplant demonstrated improved QoL measures and lab work related to underlying condition.
Weight gain and GI tolerance, which led to improvement in QoL measures
Glycemic control with a reduction in HbA1C
Improvement in creatinine and GFR, with stable BUN levels
References:
1. Eichelberger K and Bailey M. P34 ‐ Improved GI Tolerance, Quality of Life, and Weight Gain in an Adult Ulcerative Colitis, Renal Transplant Patient Using a Plant‐Based Diabetes Specific Enteral Formula. GI and Other Nutrition and Metabolic-Related Topics Poster Abstracts. ASPEN Nutrition Science & Practice Conference: April 20-23, 2023 (Las Vegas, NV). JPEN J Parenter Enteral Nutr. 2023 April;47(S71-246): S113-114 https://doi.org/10.1002/jpen.2491
2. Orlando Health Digestive Health Institute, Windermere, Florida
3. Kate Farms, Marlton, New Jersey
Loading form...
We'll have your form in just a moment